Private today. Publicly traded in months.
Insight Priya Menon 26 Jun 2026

Uplisting from OTC to Nasdaq.

Many companies become public on the OTC Markets first, then move up to a national exchange. Here is what uplisting is, the standards you have to clear, the role of a reverse split, and how the application and timing tend to work.

Uplisting is moving a company’s shares from the OTC Markets to a national securities exchange such as Nasdaq or NYSE American. The company applies to the exchange, shows it meets the exchange’s quantitative and governance standards, and, once approved, its stock trades on the exchange instead of over the counter.

Key takeaways
  • Uplisting moves an existing public company from OTC quotation to an exchange listing — the same company, a more visible and liquid venue.
  • Companies often start on OTC because entry thresholds are lower, then uplist once they can meet the exchange standards.
  • Exchanges test a bid price (Nasdaq generally US$4.00 to list, US$1.00 to continue), public float, shareholder numbers, financial standards and governance.
  • A reverse stock split is a common tool to lift the bid price above the entry threshold before applying.
  • The company applies directly to the exchange; timing depends on readiness and review, and the exact standards are confirmed with counsel.

What uplisting is

A public company’s shares can trade in two broad places: over the counter, through the OTC Markets tiers (OTCQX, OTCQB and the Pink market), or on a national securities exchange such as Nasdaq or NYSE American. Uplisting is the move from the former to the latter. It is not a new company, a new registration, or a fresh IPO — it is the same reporting company applying to have its already-public shares listed and traded on an exchange. When the exchange approves the application and the listing goes effective, the stock stops being an over-the-counter quote and starts trading on Nasdaq or NYSE American, with the visibility, index eligibility, institutional access and generally deeper liquidity that an exchange listing brings.

Why start on OTC and uplist later

Many companies deliberately become public on the OTC Markets first and uplist afterward, and there is a sound logic to it. The OTC tiers have lower entry thresholds than the exchanges, so a company can become publicly quoted sooner, at lower cost, and with less scale than Nasdaq or NYSE American require at the outset. That early public status is useful in itself: it lets a business build a reporting track record, establish a shareholder base and some trading history, and, where needed, raise capital — all while it grows toward the exchange standards. When the company is large enough and its stock robust enough to meet those standards, it uplists. This staged path — public early on OTC, exchange-listed once qualified — is one of the most common routes we see, and it fits naturally with a reverse takeover that lands a company on the OTC Markets to begin with. It also lets management pick the moment to uplist rather than forcing scale before the business is ready.

The standards you have to clear

An exchange listing is a privilege granted against defined criteria, and uplisting means demonstrating that the company meets them. The tests are both quantitative and qualitative, and while the precise numbers vary by exchange and by the listing tier or standard chosen, the categories are consistent. Described qualitatively, they are:

Minimum bid priceThe share price must be at or above a set floor. Nasdaq generally requires a US$4.00 minimum bid price to list (certain tiers permit a US$3.00 or US$2.00 alternative where other criteria are met), and US$1.00 to continue listing. This is the standard that most often drives a reverse split before uplisting.
Public float & market valueA minimum number of publicly held (non-affiliate) shares and a minimum market value of that public float, so there is a genuine, tradable supply of stock in independent hands.
Shareholders / holdersA minimum number of round-lot or public holders, evidencing real distribution rather than a stock concentrated in a few hands.
Financial standardsOne of several alternative tests — based on stockholders’ equity, income, market capitalisation, or assets and revenue — at least one of which the company must satisfy. Exchanges let issuers qualify under whichever standard fits their profile.
Corporate governanceBoard independence, an audit committee and other committees, a code of conduct, independent director oversight and related requirements — the governance an exchange expects of a listed company.
Reporting & auditCurrent SEC reporting (10-K, 10-Q, 8-K) and audited financial statements from a PCAOB-registered auditor. Being behind on reporting is a bar to listing.

The specific dollar thresholds, holder counts and float tests differ between Nasdaq’s tiers and NYSE American, and they change over time. The figures above are general reference points, not a checklist for any particular company; the applicable standard is confirmed with qualified US securities counsel.

The reverse split for the bid price

The requirement that trips up more uplistings than any other is the minimum bid price. Many OTC-quoted stocks trade well below US$4.00 — sometimes at a few cents — and no amount of float or equity fixes a price that is simply too low to qualify. The standard tool is a reverse stock split: the company reduces its share count by a set ratio (say one-for-ten), which proportionately raises the per-share price without changing anyone’s percentage ownership or the company’s total value. A stock at US$0.40 becomes, in principle, US$4.00 after a one-for-ten split. A reverse split is usually authorised by the board under existing shareholder approval and effected with the transfer agent and FINRA before the listing application, timed so that the post-split price can sustain the bid-price standard, not just touch it briefly. It is a routine, legitimate step — but it should be done deliberately as part of an uplisting plan, not reactively, and its sizing is a matter for the company with its advisers.

The application and the process

Uplisting is an application made directly to the exchange. In outline, the company confirms which listing standard it will qualify under, puts the necessary pieces in place — the bid price (via a reverse split if needed), the float and holder distribution, the governance structure including independent directors and committees, and current reporting — and then files a listing application with supporting documentation. The exchange reviews the application, may raise questions or request changes, and, once satisfied that the standards are met, approves the company for listing. The stock then begins trading on Nasdaq or NYSE American under its ticker. Because an uplisting company is already an SEC reporting company, this is a listing exercise rather than a fresh registration of the company, though any concurrent capital raise has its own securities-law steps handled with counsel and a broker-dealer.

Timing

There is no fixed clock on an uplisting, because most of the elapsed time is preparation rather than exchange review. A company that already meets the float, holder and financial standards, has clean current reporting and the right governance in place, and needs only to complete its application can move relatively quickly. A company that has to build toward the standards first — growing the float, distributing shares to more holders, appointing independent directors and forming committees, or carrying out a reverse split — should plan on the time those steps take, plus the exchange’s review. In practice the honest answer to “how long?” is “as long as it takes to genuinely meet the standards, then the review period on top,” and we plan uplistings against readiness rather than a promised date. As with every step described here, the applicable standards and the structure of any related financing are confirmed with qualified US securities counsel; our role is to plan the path and coordinate the specialists. For the venues themselves, see our listing venues overview.

Planning to uplist from OTC to Nasdaq? Let us map the standards you need to clear.

Start an enquiry →
Q1What is uplisting?

Uplisting is moving a company’s shares from the OTC Markets to a national securities exchange such as Nasdaq or NYSE American. The company applies to the exchange, demonstrates that it meets the exchange’s quantitative and governance standards, and, once approved, its stock begins trading on the exchange instead of over the counter. It is the same company, listed on a more visible and more liquid venue.

Q2What is the minimum bid price to list on Nasdaq?

Nasdaq generally requires a minimum bid price of US$4.00 per share to list initially (certain tiers allow a US$3.00 or US$2.00 alternative where other criteria are met), and US$1.00 to continue listing. A company whose OTC price is below the entry threshold often carries out a reverse stock split before applying so that the bid price qualifies. The exact standard for a given company is confirmed with counsel.

Q3Why do companies start on OTC and then uplist?

The OTC Markets have lower entry thresholds than the exchanges, so a company can become publicly quoted sooner and at lower cost, then grow into the exchange standards. Starting on OTC lets a business establish a reporting record, a shareholder base and some trading history, and raise capital, before applying to uplist to Nasdaq or NYSE American when it can meet the bid price, float, holder and governance requirements.

Written by

Priya Menon

Head of Markets & Listings, Reverse Takeover

Priya Menon leads markets and listings at Reverse Takeover, covering exchange listing standards, SEC reporting readiness and uplisting from the OTC Markets to Nasdaq or NYSE American. She helps companies plan the move from an OTC quotation to an exchange listing against the standards that actually apply.

Writes on exchange listing standards, SEC reporting readiness, uplisting and the OTC Markets.

This page is general, educational information about US listing routes and is not investment, legal, tax, or accounting advice, nor an offer or solicitation. Regulatory details change and vary by circumstance; obtain advice from qualified US securities counsel. See our disclosures.